Search Ontology:
ChEBI

holomycin

Term ID
CHEBI:156451
Synonyms
  • 6-(acetylamino)-1,2-dithiolo[4,3-b]pyrrol-5(4H)-one
  • 6-acetamido-1,2-dithiolo[4,3-b]pyrrol-5(4H)-one
  • N-(4,5-dihydro-5-oxo-1,2-dithiolo-[4,3-b]pyrrol-6-yl)acetamide
  • N-(5-oxo-4,5-dihydro[1,2]dithiolo[4,3-b]pyrrol-6-yl)acetamide
  • N-(5-oxo-4H-dithiolo[4,3-b]pyrrol-6-yl)acetamide
  • N-demethylthiolutin
  • N-{5-oxo-4H,5H-[1,2]dithiolo[4,3-b]pyrrol-6-yl}acetamide
Definition
A dithiolopyrrolone antibiotic that is 4,5-dihydro[1,2]dithiolo[4,3-b]pyrrole in which the hydrogens at positions 5 and 6 have been replaced by oxo and acetamido groups, respectively. It is an inhibitor of DNA-dependent RNA polymerase, and exhibits antibacterial and antitumour properties.
References
  • cas:488-04-0
  • metacyc.compound:CPD-17940
  • pubmed:11158751
  • pubmed:12426344
  • pubmed:16890414
  • pubmed:17606690
  • pubmed:21041678
  • pubmed:21339958
  • pubmed:21342467
  • pubmed:21504228
  • pubmed:22344669
  • pubmed:23097183
  • pubmed:23147422
  • pubmed:23572522
  • pubmed:24141227
  • pubmed:24323287
  • pubmed:27018252
  • pubmed:28209778
  • pubmed:28627048
  • pubmed:28740758
  • pubmed:30194098
  • pubmed:32642829
  • pubmed:468729
  • pubmed:863793
  • pubmed:894386
  • reaxys:188430
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from holomycin
Phenotype where environments contain holomycin
Phenotype modified by environments containing holomycin
Phenotype affecting holomycin
Human Disease Model